These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17537517)

  • 1. Production, purification and functional validation of human secreted amyloid precursor proteins for use as neuropharmacological reagents.
    Turner PR; Bourne K; Garama D; Carne A; Abraham WC; Tate WP
    J Neurosci Methods; 2007 Aug; 164(1):68-74. PubMed ID: 17537517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.
    Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L
    J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1.
    Boo JH; Sohn JH; Kim JE; Song H; Mook-Jung I
    Biochem Biophys Res Commun; 2008 Aug; 372(4):913-7. PubMed ID: 18538664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor protein.
    Gralle M; Oliveira CL; Guerreiro LH; McKinstry WJ; Galatis D; Masters CL; Cappai R; Parker MW; Ramos CH; Torriani I; Ferreira ST
    J Mol Biol; 2006 Mar; 357(2):493-508. PubMed ID: 16436282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains.
    Corrigan F; Pham CL; Vink R; Blumbergs PC; Masters CL; van den Heuvel C; Cappai R
    Brain Res; 2011 Mar; 1378():137-43. PubMed ID: 21215734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drugs and ectodomain shedding of the amyloid precursor protein.
    Leuchtenberger S; Maler J; Czirr E; Ness J; Lichtenthaler SF; Esselmann H; Pietrzik CU; Wiltfang J; Weggen S
    Neurodegener Dis; 2009; 6(1-2):1-8. PubMed ID: 18349521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of quantitative LC-MS surrogate peptide methodology in the analysis of the amyloid beta peptide (Abeta) biosynthetic intermediate protein APP-betaCTF.
    Cantone JL; Xu-Lin A; Toyn JH; Drexler DM
    J Neurosci Methods; 2009 Jun; 180(2):255-60. PubMed ID: 19464516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-1 promotes beta-amyloid production by a secretase-independent mechanism.
    Araki W; Kume H; Oda A; Tamaoka A; Kametani F
    Biochem Biophys Res Commun; 2009 Feb; 380(1):111-4. PubMed ID: 19167357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP.
    Talamagas AA; Efthimiopoulos S; Tsilibary EC; Figueiredo-Pereira ME; Tzinia AK
    Neurobiol Dis; 2007 Dec; 28(3):304-15. PubMed ID: 17761425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent and sequence-sensitive effects of amyloid-beta peptide on neurosteroidogenesis in human neuroblastoma cells.
    Schaeffer V; Meyer L; Patte-Mensah C; Eckert A; Mensah-Nyagan AG
    Neurochem Int; 2008 May; 52(6):948-55. PubMed ID: 18295935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
    Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
    Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity.
    Yang HQ; Pan J; Ba MW; Sun ZK; Ma GZ; Lu GQ; Xiao Q; Chen SD
    Eur J Neurosci; 2007 Jul; 26(2):381-91. PubMed ID: 17650113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
    Harris B; Pereira I; Parkin E
    Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.
    Russo O; Cachard-Chastel M; Rivière C; Giner M; Soulier JL; Berthouze M; Richard T; Monti JP; Sicsic S; Lezoualc'h F; Berque-Bestel I
    J Med Chem; 2009 Apr; 52(8):2214-25. PubMed ID: 19334715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
    Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
    J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular sAPP retention in response to Abeta is mapped to cytoskeleton-associated structures.
    Henriques AG; Vieira SI; Crespo-López ME; Guiomar de Oliveira MA; da Cruz e Silva EF; da Cruz e Silva OA
    J Neurosci Res; 2009 May; 87(6):1449-61. PubMed ID: 19105196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting gene expression of alpha3 nicotinic receptor in SH-SY5Y cells with the effects on APP metabolism and antioxidation in Alzheimer's disease.
    Tang Z; An Y; Qi XL; Xiao Y; Shan KR; Guan ZZ
    Neurochem Int; 2008 Nov; 53(5):112-7. PubMed ID: 18647633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 1,2,3,4-tetrahydroisoquinoline derivatives as modulators of proteolytic cleavage of amyloid precursor proteins.
    Hu MK; Liao YF; Chen JF; Wang BJ; Tung YT; Lin HC; Lee KP
    Bioorg Med Chem; 2008 Feb; 16(4):1957-65. PubMed ID: 18024043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effect of acetyl-L-carnitine on amyloid precursor protein metabolism in hippocampal neurons.
    Epis R; Marcello E; Gardoni F; Longhi A; Calvani M; Iannuccelli M; Cattabeni F; Canonico PL; Di Luca M
    Eur J Pharmacol; 2008 Nov; 597(1-3):51-6. PubMed ID: 18801359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting alpha-secretase cleavage of beta-amyloid with engineered proteolytic antibody fragments.
    Kasturirangan S; Brune D; Sierks M
    Biotechnol Prog; 2009; 25(4):1054-63. PubMed ID: 19572401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.